Cost relation between severity of Alzheimer's disease and cognitive and functional impairment

Background and Objective: This study aims to identify the relationship between costs of medical and social attention in patients with dementia of Alzheimer disease (AD) type and clinical and sociodemographic data of patients and their caregivers. Patients and Method: It was an analytic observation study in a cohort of patients diagnosed with Alzheimer's disease who received ambulatory attention. Information about the use of health-related resources was collected and costs were estimated from a societal perspective. Indirect costs were calculated using a replacement cost approach. Patients and caregivers were examined with the Mini-Mental State Examination (MMSE), the Rapid Disability Rating Scale (RDRS-2), the Neurospychiatric Inventory (NPI), the Burden Interview (BI) and the Resource Utilization in Dementia (RUD). Patients were grouped taking into account the score obtained in the MMSE. Results: A cohort of 417 patients, mean age (SD) 75.2 (6.6) years, 71% females, was studied. Disease severity levels were distributed as follows: MMSE, 26% for MMSE >19, 66% for MMSE=19-11, and 8% for MMSE <11. 69% of caregivers were women, with a mean age of 57.1 (15.8) years.. The cost per patient and per month was estimated to be 419.3 (sic) for MMSE >19, 641.9 C for MMSE=19-11, and 1150.6 (sic) for MMSE <11. Conclusions: The societal cost of AD increases dramatically with increasing disease severity. Caregiver burden and sex as well as the marital status of patients are associated with the cost of the disease.